共 142 条
[1]
Phan TA(2005)Incontinentia pigmenti case series: clinical spectrum of incontinentia pigmenti in 53 female patients and their relatives Clin Exp Dermatol 30 474-480
[2]
Wargon O(1993)Incontinentia pigmenti (Bloch-Sulzberger syndrome) J Med Genet 30 53-59
[3]
Turner AM(2000)Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The international Incontinentia Pigmenti (IP) consortium Nature 405 466-472
[4]
Landy SJ(2002)Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology J Am Acad Dermatol 47 169-187
[5]
Donnai D(2011)Incontinentia pigmenti--ophthalmological observation of a series of cases and review of the literature Br J Ophthalmol 95 11-16
[6]
Smahi A(2017)Successful treatment of refractory proliferative retinopathy of Incontinentia Pigmenti by intravitreal Ranibizumab as adjunct therapy in a 4-year-old child Retin Cases Brief Rep 11 352-355
[7]
Courtois G(2018)Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity Cochrane Database Syst Rev 1 CD009734-615
[8]
Vabres P(2011)Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity N Engl J Med 364 603-266
[9]
Yamaoka S(2018)The role of tumor angiogenesis as a therapeutic target in colorectal cancer Expert Rev Anticancer Ther 18 251-1795
[10]
Heuertz S(2007)Mechanisms of adverse effects of anti-VEGF therapy for cancer Br J Cancer 96 1788-376